» Articles » PMID: 7585549

Regulation of the Expression of E-cadherin on Human Cancer Cells by Gamma-linolenic Acid (GLA)

Overview
Journal Cancer Res
Specialty Oncology
Date 1995 Nov 1
PMID 7585549
Citations 26
Authors
Affiliations
Soon will be listed here.
Abstract

E-cadherin is a cell to cell adhesion molecule which acts as a suppressor of metastasis. This study examined the effect of gamma-linolenic acid (GLA), a n-6 polyunsaturated fatty acid, on the expression of E-cadherin in human cancer cells. Western blotting studies demonstrated that treatment of cells with GLA for 24 h increased the expression of E-cadherin in lung, colon, breast, melanoma, and liver cancer cells, but not in endothelial cells and fibroblasts. The results were confirmed by immunocytochemistry. In contrast, two other n-6 fatty acids, linoleic acid and arachidonic acid, failed to induce these changes. The increased expression of E-cadherin was correlated with reduced in vitro invasion and increased aggregation, indicating that the increased E-cadherin expression induced by GLA was biologically active. These data add GLA to the short list of E-cadherin up-regulatory factors. The up-regulation of E-cadherin expression in human cancer cells may contribute to the anticancer properties of GLA.

Citing Articles

Anti-infective activities of long-chain fatty acids against foodborne pathogens.

Borreby C, Lillebaek E, Kallipolitis B FEMS Microbiol Rev. 2023; 47(4).

PMID: 37437907 PMC: 10368373. DOI: 10.1093/femsre/fuad037.


Distinctive Prognostic Value and Cellular Functions of Osteopontin Splice Variants in Human Gastric Cancer.

Hao C, Cui Y, Lane J, Jia S, Ji J, Jiang W Cells. 2021; 10(7).

PMID: 34359989 PMC: 8305399. DOI: 10.3390/cells10071820.


The Valproate Mediates Radio-Bidirectional Regulation Through RFWD3-Dependent Ubiquitination on Rad51.

Liu G, Lim D, Cai Z, Ding W, Tian Z, Dong C Front Oncol. 2021; 11:646256.

PMID: 33842359 PMC: 8029989. DOI: 10.3389/fonc.2021.646256.


Impact of pigment epithelium-derived factor on colorectal cancer and .

Harries R, Owen S, Ruge F, Morgan M, Li J, Zhang Z Oncotarget. 2018; 9(27):19192-19202.

PMID: 29721193 PMC: 5922387. DOI: 10.18632/oncotarget.24953.


Targeting RhoC by Way of Ribozyme Trangene in Human Breast Cancer Cells and its Impact on Cancer Invasion.

Lane J, Martin T, Jiang W World J Oncol. 2017; 1(1):7-13.

PMID: 29147173 PMC: 5649728. DOI: 10.4021/wjon2010.01.1202.